Cancer risks among relatives of children with Hodgkin and non-Hodgkin lymphoma

International Journal of Cancer

Volumn 123, Issue 6, 2008, Pages 1407-1410

  Pang, Dong ^a,b   Alston, Robert D ^a   Eden, Tim O B ^a   Birch, Jillian M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Children; CNS tumour; Familial cancer risk; Hodgkin lymphoma; Non Hodgkin lymphoma; Population based

Indexed keywords

ADOLESCENT; AGE; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; FAMILY; FAMILY HISTORY; GENETIC SUSCEPTIBILITY; HODGKIN DISEASE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PARENT; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; UNITED KINGDOM;

CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASMS; PEDIGREE; REGISTRIES; RISK FACTORS;

EID: 49749107268     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23651     Document Type: Article

References (39)

1. Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 2005;106: 668-72.
2. Chatterjee N, Hartge P, Cerhan JR, Cozen W, Davis S, Ishibe N, Colt J, Goldin L, Severson RK. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 2004;13:1415-21.
3. Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, Olsen JH, Hemminki K, Linet MS. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004;100:1902-8.
4. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin's disease in siblings. N Engl J Med 1977;296:248-50.
5. Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982;49:2197-200.
6. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, Taylor CR, Hamilton AS, Deapen DM, Rappaport EB. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995;332:413-18.
7. Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, Haim N, Shachar MB, Epelbaum R, Barchana M, Cohen R, Ben Yehuda D. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: results and limitations of a registry-linked study. Cancer 2000;88:2357-66.
8. Kerber RA, O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 2005;103:1906-15.
9. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, Sulem P, Kristjansson K, Arnason S, Gulcher JR, Bjornsson J, Kong A, Thorsteinsdottir U, Stefansson K. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
10. Wang SS, Slager SL, Brennan P, Holly EA, De Sanjose S, Bernstein L, Boffetta P, Cerhan JR, Maynadie M, Spinelli JJ, Chiu BC, Cocco PL, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10,211 cases and 11,905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;109:3479-88.
11. Hemminki K, Mutanen P. Parental cancer as a risk factor for nine common childhood malignancies. Br J Cancer 2001;84:990-3.
12. Olsen JH, Boice JD, Jr, Seersholm N, Bautz A, Fraumeni JF, Jr. Cancer in the parents of children with cancer. N Engl J Med 1995; 333:1594-9.
13. Winther JF, Sankila R, Boice JD, Tulinius H, Bautz A, Barlow L, Glattre E, Langmark F, Moller TR, Mulvihill JJ, Olafsdottir GH, Ritvanen A, et al. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet 2001;358: 711-17.
14. Le Bihan C, Moutou C, Chompret A, Abel A, Poisson N, Brugieres L, Lemerle J, Bonaiti-Pellie C. Cancers in relatives of children with non-Hodgkin's lymphoma. Leuk Res 1996;20:181-6.
15. Rudant J, Menegaux F, Leverger G, Baruchel A, Nelken B, Bertrand Y, Hartmann O, Pacquement H, Verite C, Robert A, Michel G, Marguerite G, et al. Family history of cancer in children with acute leukemia. Hodgkin's lymphoma or non-Hodgkin's lymphoma: the. ESCALE study (SFCE). Int J Cancer 2007;121:119-26.
16. Pang D, McNally R, Kelsey A, Birch JM. Cancer incidence and mortality among the parents of a population-based series of 2604 children with cancer. Cancer Epidemiol Biomarkers Prev 2003;12:538-44.
17. Shugart YY, Collins A. Combined segregation and linkage analysis of 59 Hodgkin's disease families indicates the role of HLA determinants. Eur J Hum Genet 2000;8:460-3.
18. Alexander FE, Jarrett RF, Cartwright RA, Armstrong AA, Gokhale DA, Kane E, Gray D, Lawrence DJ, Taylor GM. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve). Cancer Epidemiol Biomarkers Prev 2001;10:705-9.
19. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am J Pathol 1987;129:86-91.
20. Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol 2003;56:811-16.
21. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, Pallesen G, Gulley ML, Khan G, O'Grady J, Hummel M, Preciado MV, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70: 375-82.
22. Preciado MV, Diez B, Grinstein S. Epstein Barr virus in Argentine pediatric Hodgkin's disease. Leuk Lymphoma 1997;24:283-90.
23. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 1998;7:1117-21.
24. Armstrong AA, Alexander FE, Paes RP, Morad NA, Gallagher A, Krajewski AS, Jones DB, Angus B, Adams J, Cartwright RA, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993;142:1683-8.
25. Armstrong AA, Alexander FE, Cartwright R, Angus B, Krajewski AS, Wright DH, Brown I, Lee F, Kane E, Jarrett RF. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia 1998;12:1272-6.
26. Kusuda M, Toriyama K, Kamidigo NO, Itakura H. A comparison of epidemiologic, histologic, and virologie studies on Hodgkin's disease in western Kenya and Nagasaki. Japan. Am J Trop Med Hyg 1998; 59:801-7.
27. McNally RJ, Alston RD, Cairns DP, Eden OB, Birch JM. Geographical and ecological analyses of childhood acute leukaemias and lymphomas in north-west England. Br J Haematol 2003;123:60-5.
28. Kamper PM, Kjeldsen E, Clausen N, Bendix K, Hamilton-Dutoit S, d'Amore F. Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings. Br J Haematol 2005;129:615-17.
29. Wang Q, Lasset C, Desseigne F, Frappaz D, Bergeron C, Navarro C, Ruano E, Puisieux A. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 1999;59:294-7.
30. Ricciardone MD, Ozcelik T, Cevher B, Ozdag H, Tuncer M, Gurgey A, Uzunalimoglu O, Cetinkaya H, Tanyeli A, Erken E, Ozturk M. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999;59:290-3.
31. Side L, Taylor B, Cayouette M, Conner E, Thompson P, Luce M, Shannon K. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type I and malignant myeloid disorders. N Engl J Med 1997;336:1713-20.
32. Bougeard G, Charbonnier F, Moerman A, Martin C, Ruchoux MM, Drouot N, Frebourg T. Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet 2003;72:213-16.
33. Kruger S, Kinzel M, Walldorf C, Gottschling S, Bier A, Tinschert S, von Stackeiberg A, Henn W, Gorgens H, Boue S, Kolble K, Buttner R, et al. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours. HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet 2008;16:62-72.
34. Scott RH, Homfray T, Huxter NL, Mitton SG, Nash R, Potter MN, Lancaster D, Rahman N. Familial T-cell non-Hodgkin lymphoma caused by biallelic MSH2 mutations. J Med Genet 2007;44:e83.
35. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomaki P, Mecklin JP, Jarvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81:214-18.
36. de Wind N, Dekker M, van Rossum A, van der Valk M, te Riele H. Mouse models for hereditary nonpolyposis colorectal cancer. Cancer Res 1998;58:248-55.
37. Reese JS, Liu L, Gerson SL. Repopulating defect of mismatch repair-deficient hematopoietic stem cells. Blood 2003;102:1626-33.
38. Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 1994;47: 89-96.
39. Perrillat F, Clavel J, Jaussent I, Baruchel A, Leverger G, Nelken B, Philippe N, Schaison G, Sommelet D, Vilmer E, Bonaiti-Pellie C, Hemon D. Family cancer history and risk of childhood acute leukemia (France). Cancer Causes Control 2001;12:935-41.